Stay updated on Relatlimab Safety in B-Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Safety in B-Cell Malignancies Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a note that PubMed publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2. The previous PubMed auto-generated text and revision note of v3.2.0 were removed.
    Difference
    0.1%
    Check dated 2025-11-26T08:31:33.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The generic funding-status notice on the page was removed; the core study details (title, conditions, locations, eligibility) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-19T08:00:09.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The updates appear to be cosmetic UI/layout adjustments that do not modify the study details, inclusion/exclusion criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T02:41:36.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    - Added a government funding and operating-status notice (impactful; affects reliability and user expectations). - Updated software version to v3.2.0 (administrative change). - Removed the specific term 'B-cell chronic lymphocytic leukemia' (removal of a medical term; less impactful unless the page was about diseases).
    Difference
    3%
    Check dated 2025-10-06T15:58:43.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T09:53:17.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top element has been removed.
    Difference
    0.1%
    Check dated 2025-09-15T00:16:56.000Z thumbnail image

Stay in the know with updates to Relatlimab Safety in B-Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Safety in B-Cell Malignancies Clinical Trial page.